Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may significantly reduce the risk of dementia, particularly in individuals with type 2 ...

After Trainor shared a snapshot of her new figure on Instagram, an online critic cattily commented: "Ozempic is crazy." Noted diet guru Dr. Stuart Fischer, who has not treated Trainor, said he ...

These included GLP-1 receptor agonists like Ozempic (which promote insulin production and feelings of fullness); SGLT2 inhibitors (which prevent the kidneys from reabsorbing glucose, forcing its ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

The S&P 500 briefly entered bear market territory on Monday, down 21% from recent highs. Stocks have cratered since Wednesday's tariff announcement, with the selling continuing on Monday.

A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro ...

However, investors and everyday Americans are expressing fears of a recession — especially after Monday’s stock swings flirted with the threshold for a so-called “bear market.” A “bear ...

The drug semaglutide, found in popular brands like Wegovy and Ozempic, looks especially promising in lowering the chances of memory problems, a hallmark of dementia. The study looked at nearly ...

1:54 GLP-1 drugs like Ozempic, Wegovy reduce Alzheimer’s risk for those with diabetes Two major studies published Monday in JAMA Neurology found that GLP-1 medications are linked to a lower risk ...

Semaglutide is one type of GLP-1RA drug approved in the UK for diabetes management (Ozempic) and weight loss (Wegovy)Credit: Alamy These were GLP-1 receptor agonists (GLP-1RAs), which include ...

Novo Nordisk (NYSE:NVO)) is going big in Brazil. The drugmaker behind Ozempic and Wegovy just dropped a $1.09 billion investment to supercharge its manufacturing plant in Montes Claros.

Not one but two new studies published today have linked GLP-1 drugs like Ozempic to a decreased risk of developing dementia. There is currently no cure for Alzheimer’s, which affects an ...